_________________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
__________________________________
FORM 8-K
_________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
July 2, 1997
__________
Date of Report (Date of earliest event reported)
ACCUHEALTH, INC.
(Exact name of registrant as specified in its charter)
New York 0-17292 13-3176233
_____________ ________________ ____________________
(State or other Commission File Number (I.R.S. Employer
jurisdiction of Identification
incorporation or Number)
organization)
1575 Bronx River Avenue, Bronx, New York 10460
_________________________________________________________
(Address of Principal Executive Offices) (Zip Code)
(718) 518-9511
__________________________________________________________
(Registrant's telephone number, including area code)
Not Applicable
___________________________________________________________
(Former name or former address, if changed since last report.)
_________________________________________________________________
Item 2. Acquisition or Disposition of Assets
On July 2, 1997, Accuhealth, Inc. (the "Company"), completed
the acquisition of ProHealthCare Infusion Services, Inc.
("PHCIS"). The acquisition was effected pursuant to an Agreement
and Plan of Merger dated as of March 14, 1997 (the "Merger
Agreement") among the Company, ACH Acquiring Corp., a wholly
owned subsidiary of the Company, PHCIS, ProHealthCare, Inc., the
parent of PHCIS, and two stockholders of PHCIS, Thomas Laurita
and David Brian Cohen. The consideration for the merger was the
issuance of 300,000 restricted shares of the Company's Common
Stock. The Company would be required to issue additional shares
if certain gross profit targets are met. 206,187 of the shares
of Common Stock issued at the closing have been deposited in
escrow to be available to satisfy potential indemnification
claims of the Company. The description herein of the transaction
is qualified in its entirety by reference to the Merger
Agreement, a copy of which was filed as Exhibit 10.30 to the
Company Annual Report on form 10-K for the fiscal year ended
March 31, 1997.
Item 7. Financial Statements and Exhibits.
(a) and (b) Financial statement of businesses
acquired and pro forma financial
information.
The Company will file the required financial statements for
PHCIS and the required pro forma financial information as soon as
practicable, but not later than 60 days after the date that this
report on Form 8-K must be filed.
(c) Exhibits
10.30 Agreement and Plan of Merger dated as of March 14,
1997 among Accuhealth, Inc., ACH Acquiring Corp.,
ProHealthCare, Inc., ProHealthCare Infusion
Services, Inc., Thomas Laurita and David Brian
Cohen (incorporated herein by reference to Exhibit
10.30 to the Company's Annual Report on Form 10-K,
dated June 30, 1997).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
ACCUHEALTH, INC
By: /s/ Glenn C. Davis
________________________
Chief Executive Officer,
President and Director
Dated July 16, 1997
EXHIBIT INDEX
10.30 Agreement and Plan of Merger dated as of March 14,
1997 among Accuhealth, Inc., ACH Acquiring Corp.,
ProHealthCare, Inc., ProHealthCare Infusion
Services, Inc. Thomas Laurita and David Brian
Cohen (incorporated herein by reference to Exhibit
10.30 to the Company's Annual Report on Form 10-K,
dated June 30, 1997).
